Lives saved by public health restrictions over the Victorian COVID-19 Delta variant epidemic wave, Aug-Nov 2021.
Delport D, Sacks-Davis R, Abeysuriya RG, Hellard M, Scott N
COVID-19
Keeping kids in school: modelling school-based testing and quarantine strategies during the COVID-19 pandemic in Australia.
Abeysuriya RG, Sacks-Davis R, Heath K, Delport D, Russell FM, Danchin M, Hellard M, McVernon J, Scott N
COVID-19
Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis.
Artenie A, Stone J, Fraser H, Stewart D, Arum C, Lim AG, McNaughton AL, Trickey A, Ward Z, Abramovitz D, Alary M, Astemborski J, Bruneau J, Clipman SJ, Coffin CS, Croxford S, DeBeck K, Emanuel E, Hayashi K, Hermez JG, Low-Beer D, Luhmann N, Macphail G, Maher L, Palmateer NE, Patel EU, Sacks-Davis R, Van Den Boom W, van Santen DK, Walker JG, Hickman M, Vickerman P; HIV and HCV Incidence Review Collaborative Group (including Dietze P and Hellard M)
Hepatitis C HIV + AIDS Injecting Drug Use
COVID-19 epidemic modelling for policy decision support in Victoria, Australia 2020-2021.
Scott N, Abeysuriya RG, Delport D, Sacks-Davis R, Nolan J, West D, Sutton B, Wallace EM, Hellard M
COVID-19
Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study.
Isfordink CJ, Boyd A, Sacks-Davis R, van Santen DK, Smit C, Martinello M, Stoove M, Berenguer J, Wittkop L, Klein MB, Rauch A, Salmon D, Lacombe K, Stewart A, Schinkel J, Doyle JS, Hellard M, van der Valk M, Matthews GV, InCHEHC study group
Hepatitis C HIV + AIDS
Estimating the proportion of Victorians infected with COVID-19 during the Omicron BA.1 epidemic wave of January 2022 in Australia.
Altermatt A, Heath K, Saich F, Lee Wilkinson A, Scott N, Sacks-Davis R, Young K, Stoové M, Gibney KB, Hellard M
COVID-19